Total Payments
$7,369
2024 Payments
$908.56
Companies
27
Transactions
243
Medicare Patients
1,482
Medicare Billing
$135,600
Payment Breakdown by Category
Food & Beverage$5,789 (78.6%)
Consulting$1,550 (21.0%)
Travel$29.91 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,789 | 239 | 78.6% |
| Consulting Fee | $1,550 | 3 | 21.0% |
| Travel and Lodging | $29.91 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $2,222 | 82 | $0 (2024) |
| Intersect ENT, Inc. | $762.88 | 16 | $0 (2021) |
| Spirox Inc | $750.00 | 2 | $0 (2017) |
| Acclarent, Inc | $742.27 | 19 | $0 (2023) |
| ALK-Abello, Inc | $543.24 | 30 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $326.47 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $326.43 | 15 | $0 (2024) |
| GENZYME CORPORATION | $243.21 | 9 | $0 (2024) |
| Integra LifeSciences Corporation | $181.21 | 4 | $0 (2024) |
| Xoran Technologies | $176.65 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $908.56 | 44 | Optinose US, Inc. ($239.31) |
| 2023 | $694.39 | 36 | Optinose US, Inc. ($292.91) |
| 2022 | $735.55 | 38 | ALK-Abello, Inc ($219.93) |
| 2021 | $909.01 | 34 | Optinose US, Inc. ($331.73) |
| 2020 | $1,190 | 22 | OptiNose US, Inc. ($945.34) |
| 2019 | $888.17 | 27 | OptiNose US, Inc. ($199.14) |
| 2018 | $494.37 | 16 | Integra LifeSciences Corporation ($135.92) |
| 2017 | $1,549 | 26 | Spirox Inc ($750.00) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/11/2024 | Integra LifeSciences Corporation | ACCLARENT AERA (Device), INSPIRA AIR, TruDi Probe | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: ENT | ||||||
| 10/26/2024 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Image Guided Surgery Products | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Immunology | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/10/2024 | Medtronic, Inc. | NUVENT (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Sinus Surgery | ||||||
| 09/06/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/16/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 369 | 454 | $99,363 | $29,836 |
| 2022 | 9 | 386 | 497 | $114,909 | $32,757 |
| 2021 | 8 | 379 | 524 | $135,109 | $39,521 |
| 2020 | 8 | 348 | 474 | $121,202 | $33,487 |
Total Patients
1,482
Total Services
1,949
Medicare Billing
$135,600
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 203 | $31,766 | $13,306 | 41.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 90 | 90 | $23,620 | $7,762 | 32.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 70 | 78 | $10,973 | $2,703 | 24.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 19 | 21 | $8,885 | $2,213 | 24.9% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 21 | 21 | $15,699 | $1,997 | 12.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 41 | 41 | $8,420 | $1,855 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 216 | $38,448 | $15,043 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 71 | 71 | $23,430 | $6,472 | 27.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 24 | 33 | $13,365 | $3,303 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 64 | 64 | $14,080 | $2,650 | 18.8% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 18 | 20 | $12,000 | $2,073 | 17.3% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 30 | 33 | $5,511 | $1,251 | 22.7% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 23 | 24 | $2,303 | $814.70 | 35.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $2,112 | $643.63 | 30.5% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 20 | 20 | $3,660 | $505.45 | 13.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 234 | $41,652 | $16,537 | 39.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 81 | 81 | $26,730 | $7,349 | 27.5% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 25 | 37 | $14,985 | $3,752 | 25.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 71 | 71 | $15,620 | $3,471 | 22.2% |
| 70486 | Ct scan of face | Office | 2021 | 24 | 26 | $15,600 | $2,872 | 18.4% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 11 | 17 | $10,200 | $2,386 | 23.4% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2021 | 38 | 45 | $4,277 | $1,578 | 36.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $6,045 | $1,575 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 119 | 220 | $39,160 | $12,649 | 32.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 73 | 73 | $24,090 | $5,997 | 24.9% |
About Dr. Daniel Kurtzman, MD
Dr. Daniel Kurtzman, MD is a Otolaryngology healthcare provider based in Berwyn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588753693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kurtzman, MD has received a total of $7,369 in payments from pharmaceutical and medical device companies, with $908.56 received in 2024. These payments were reported across 243 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,789).
As a Medicare-enrolled provider, Kurtzman has provided services to 1,482 Medicare beneficiaries, totaling 1,949 services with total Medicare billing of $135,600. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Berwyn, IL
- Active Since 10/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1588753693
Products in Payments
- Xhance (Drug) $2,222
- Latera (Device) $750.00
- PROPEL (Device) $582.62
- DUPIXENT (Biological) $569.68
- Odactra (Drug) $462.89
- NUCALA (Biological) $326.43
- SINUVA (Drug) $203.42
- ACCLARENT Balloon Inflation Device (Device) $180.16
- MiniCAT (Device) $176.65
- INSTRUMENTS-ENT (Device) $135.92
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) $117.56
- ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE (Device) $109.82
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $105.82
- VIVAER STYLUS (Device) $95.10
- Acclarent Aera (Device) $94.15
- Sinuva (Drug) $85.67
- Coblation - Sinus Wands (Device) $77.35
- FLEXITOUCH (Device) $75.96
- Otovel (Drug) $68.98
- NEUROMARK Device (Device) $67.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.